Browsing Tag
NYSE American
32 posts
Could Quantum eMotion Corp.’s SKV Technology acquisition strengthen its position in quantum-resilient enterprise security? (NYSE American: QNC)
Quantum eMotion Corp. has closed its SKV Technology acquisition. Find out how the deal could reshape its quantum-safe cybersecurity strategy.
Can Unusual Machines, Inc. turn fresh equity capital into a durable lead in domestic drone parts manufacturing? (NYSE American: UMAC)
Unusual Machines raises $150M to expand drone parts supply. Discover how this move could reshape U.S. manufacturing and investor sentiment.
NUBURU (BURU) revives Tekne acquisition with €52m valuation and April Golden Power filing
NUBURU (BURU) revives 70% Tekne acquisition with EUR 52M valuation and April Golden Power filing. Read what this means for defense investors.
Will PEDEVCO Corp.’s 1-for-20 reverse split strengthen its institutional appeal? (NYSE American: PED)
PEDEVCO Corp. executes a 1-for-20 reverse stock split after its Juniper merger. Discover what this means for investors and capital strategy.
How Battalion Oil Corporation’s $15m capital raise reshapes its near-term balance sheet strategy (NYSE American: BATL)
Battalion Oil Corporation raises $15M at $5.50 per share. Discover what this means for liquidity, dilution, and small-cap energy strategy in 2026.
What NUBURU, Inc.’s Maddox Defense venture means for NATO-aligned distributed manufacturing
NUBURU, Inc. partners with Maddox Defense on mobile drone manufacturing. Explore what this means for defense strategy and investor sentiment today.
How Quantum eMotion Corp.’s U.S. listing could reshape its quantum cybersecurity growth strategy
Quantum eMotion Corp. joins NYSE American as QNC. Discover how the U.S. listing could reshape its quantum cybersecurity growth strategy.
From pharmacy to property and Bitcoin: what is SRx Health Solutions building next?
SRx Health Solutions boosts Opendoor stake and goes net long crypto. Discover what this means for investors and market risk exposure.
VolitionRx Limited faces NYSE compliance deadline tied to sustained sub-US$1 share price
VolitionRx Limited receives a NYSE non-compliance notice tied to its share price. Find out what it means for investors, strategy, and what comes next.
Palatin Technologies to raise $15.8m in public offering; NYSE relisting expected Nov 12
Palatin Technologies regains NYSE American compliance and secures $15.8M for its oral MC4R obesity drug. Find out how the relisting and IND impact its biotech trajectory.